Skip to main content
Erschienen in: Diabetologia 10/2004

01.10.2004 | Short Communication

Renal disease in rats with Type 2 diabetes is associated with decreased renal nitric oxide production

verfasst von: A. Erdely, G. Freshour, D. A. Maddox, J. L. Olson, L. Samsell, C. Baylis

Erschienen in: Diabetologia | Ausgabe 10/2004

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

In several other models of chronic renal disease, decreases in renal nitric oxide activity and nitric oxide synthase (NOS) protein abundance have been demonstrated. Here, we studied diabetic obese Zucker (ZDF Gmi fa/fa) rats that develop severe hyperglycaemia and renal disease, together with their lean control animals, to determine if renal nitric oxide deficiency also occurs in this model.

Methods

Obese Zucker rats aged 10 to 12 weeks were maintained on Purina 5008 diet until 4, 8, or 11 months of age and compared with similarly maintained, 4- and 11-month-old lean Zucker rats. NOS activity and abundance of endothelial NOS (eNOS) and neuronal NOS (nNOS) were measured on homogenates of kidney cortex. Blood was analysed for glucose, lipids, creatinine, and blood urea nitrogen and kidney tissue was obtained for histology.

Results

Obese rats exhibited severe hyperglycaemia from 4 months of age and developed increasing hyperlipidaemia, proteinuria, and decreasing renal function with age compared to lean counterparts. At 4 months cortical NOS activity and nNOS abundance were lower in obese rats than in lean ones. At 11 months NOS activity remained depressed and nNOS abundance had declined further in obese rats. Glomerulosclerosis in the obese rats was mild at 4 months, becoming severe by 11 months. Lean rats had only mild age-dependent increases in glomerular injury.

Conclusions/interpretation

The chronic renal disease that occurs in hyperglycaemic, obese Zucker rats is associated with decreased renal cortical nitric oxide production and increasing renal injury, although the changes do not resemble those of diabetic nephropathy in man.
Literatur
1.
Zurück zum Zitat Schmidt RJ, Baylis C (2000) Total nitric oxide production is low in patients with chronic renal disease. Kidney Int 58:1261–1266CrossRefPubMed Schmidt RJ, Baylis C (2000) Total nitric oxide production is low in patients with chronic renal disease. Kidney Int 58:1261–1266CrossRefPubMed
2.
Zurück zum Zitat Aiello S, Noris M, Todeschini M et al. (1997) Renal and systemic nitric oxide synthesis in rats with renal mass reduction. Kidney Int 52:171–181PubMed Aiello S, Noris M, Todeschini M et al. (1997) Renal and systemic nitric oxide synthesis in rats with renal mass reduction. Kidney Int 52:171–181PubMed
3.
Zurück zum Zitat Wagner L, Riggleman A, Erdely A, Couser W, Baylis C (2002) Reduced nitric oxide synthase activity in rats with chronic renal disease due to glomerulonephritis. Kidney Int 62:532–536CrossRefPubMed Wagner L, Riggleman A, Erdely A, Couser W, Baylis C (2002) Reduced nitric oxide synthase activity in rats with chronic renal disease due to glomerulonephritis. Kidney Int 62:532–536CrossRefPubMed
4.
Zurück zum Zitat Janssen U, Phillips AO, Floege J (1999) Rodent models of nephropathy associated with type II diabetes. J Nephrol 12:159–172PubMed Janssen U, Phillips AO, Floege J (1999) Rodent models of nephropathy associated with type II diabetes. J Nephrol 12:159–172PubMed
5.
Zurück zum Zitat Maddox DA, Alavi FK, Santella RN, Zawada ET Jr (2002) Prevention of obesity-linked renal disease: age-dependent effects of dietary food restriction. Kidney Int 62:208–219CrossRefPubMed Maddox DA, Alavi FK, Santella RN, Zawada ET Jr (2002) Prevention of obesity-linked renal disease: age-dependent effects of dietary food restriction. Kidney Int 62:208–219CrossRefPubMed
6.
Zurück zum Zitat Komers R, Anderson S (2003) Paradoxes of nitric oxide in the diabetic kidney. Am J Physiol 284:F1121–F1137 Komers R, Anderson S (2003) Paradoxes of nitric oxide in the diabetic kidney. Am J Physiol 284:F1121–F1137
7.
Zurück zum Zitat Erdely A, Wagner L, Muller V, Szabo A, Baylis C (2003) Protection of Wistar Furth rat from chronic renal disease is associated with maintained renal nitric oxide synthase. J Am Soc Nephrol 14:2526–2533PubMed Erdely A, Wagner L, Muller V, Szabo A, Baylis C (2003) Protection of Wistar Furth rat from chronic renal disease is associated with maintained renal nitric oxide synthase. J Am Soc Nephrol 14:2526–2533PubMed
8.
Zurück zum Zitat Baylis C, Atzpodien EA, Freshour G, Engels K (2003) Peroxisome proliferator-activated receptor [gamma] agonist provides superior renal protection versus angiotensin-converting enzyme inhibition in a rat model of type 2 diabetes with obesity. J Pharmacol Exp Ther 307:854–860CrossRefPubMed Baylis C, Atzpodien EA, Freshour G, Engels K (2003) Peroxisome proliferator-activated receptor [gamma] agonist provides superior renal protection versus angiotensin-converting enzyme inhibition in a rat model of type 2 diabetes with obesity. J Pharmacol Exp Ther 307:854–860CrossRefPubMed
9.
Zurück zum Zitat Erdely A, Freshour G, Smith C, Engels K, Olson JL, Baylis C (2004) Protection against puromycin aminonucleoside-induced chronic renal disease in the Wistar-Furth rat. Am J Physiol 287:F81–F89CrossRef Erdely A, Freshour G, Smith C, Engels K, Olson JL, Baylis C (2004) Protection against puromycin aminonucleoside-induced chronic renal disease in the Wistar-Furth rat. Am J Physiol 287:F81–F89CrossRef
10.
Zurück zum Zitat Baylis C, Vallance P (1998) Measurement of nitrite and nitrate levels in plasma and urine—what does this measure tell us about the activity of the endogenous nitric oxide system? Curr Opin Nephrol Hypertens 7:59–62CrossRefPubMed Baylis C, Vallance P (1998) Measurement of nitrite and nitrate levels in plasma and urine—what does this measure tell us about the activity of the endogenous nitric oxide system? Curr Opin Nephrol Hypertens 7:59–62CrossRefPubMed
11.
Zurück zum Zitat Ribiere C, Jaubert AM, Gaudiot N et al. (1996) White adipose tissue nitric oxide synthase: a potential source for NO production. Biochem Biophys Res Commun 222:706–712CrossRefPubMed Ribiere C, Jaubert AM, Gaudiot N et al. (1996) White adipose tissue nitric oxide synthase: a potential source for NO production. Biochem Biophys Res Commun 222:706–712CrossRefPubMed
Metadaten
Titel
Renal disease in rats with Type 2 diabetes is associated with decreased renal nitric oxide production
verfasst von
A. Erdely
G. Freshour
D. A. Maddox
J. L. Olson
L. Samsell
C. Baylis
Publikationsdatum
01.10.2004
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 10/2004
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-004-1509-1

Weitere Artikel der Ausgabe 10/2004

Diabetologia 10/2004 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.